Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Other Solid Tumors (Poster Session)

  • You have access
    FDG-PET response to nivolumab is predictive of tumor progression and survival in non-small cell lung cancer patients
    Siavash Mehdizadeh Seraj, Mahdi Zirakchian Zadeh, Pegah Jahangiri, Fatemeh Kaghazchi, Eman Kalboush, Thomas Werner, Andrew Newberg, Stephen Hunt, Abass Alavi and Mona-Elisabeth Revheim
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1359;
  • You have access
    PSMA-PI-RADS in 68Ga-PSMA-11 PET/MRI Improve the Differentiation of Naïve Prostate Cancer and Primary Staging: Pilot Study
    Xiaoyuan LI, Shuyue Ai, Rushuai LI, Yan Xie, Fan QIU and Feng Wang
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1358;
  • You have access
    Axillary lymph node activation following Influenza vaccination on F-18 FDG PET/CT
    Eunkyung Park and Michael Graham
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1351;
  • You have access
    Immune checkpoint inhibitorsinduced Endocrinopathies on F-18 FDG PET/CT
    Ricardo Bello Martinez, Amanda Leiter, Emily Gallagher, Yasir Ahmad, Somali Gavane, Munir Ghesani, Anthony Hafez, Sherif Heiba, Arif Sheikh and Nasrin Ghesani
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1350;
  • You have access
    Verification of Automatic Detection of Prostate Cancer Lesion with68Ga-PSMA PET/CT Images Using Deep Supervised Residual U-Net
    Zhemin Huang, Yu Zhao, Xiuming Li, Chuantao Zuo, Yihui Guan, Axel Rominger, Ali Afshar-Oromieh and Kuangyu Shi
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1353;
  • You have access
    Prognostic value of semi-quantitative parameters on 18F-FDG PET/CT in patients with cardiac tumor
    JINGJING MENG, Honglei Zhao, Ziwei Zhu, Jian Jiao, Jielin Liu, Xiang Li and Xiaoli Zhang
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1352;
  • You have access
    One versus five-lesion analysis by PERCIST in lung cancer.
    Soo Jin Kwon, Joo Hyun O and Ie Ryung Yoo
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1357;
  • You have access
    Value of FDG PET/CT in predicting the simplified WHO grade of malignancy in thymic epithelial tumors
    Juan Zhao
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1355;
  • You have access
    The diagnostic value of time-of-flight 68Ga- PSMA-11 PET-MR in prostate cancer and compared with PET/CT
    Yang Fengjiao, Rushuai LI, Li-Yun Zheng and Feng Wang
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1354;
  • You have access
    The predictive role of PET/CT and bioumoral parameters in immunotherapy
    Lavinia Monaco, Irene Gotuzzo, Cinzia Crivellaro, Federica Elisei, Maria Gemelli, Diego Luigi Cortinovis, Mirko Acquati, Davide Paolo Bernasconi, Lorenzo Pilla, Paolo Bidoli, Claudio Landoni, Luca Guerra and Cristina Messa
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 1347;

Pages

  • Next
  • 1
  • 2
SNMMI

© 2025 SNMMI

Powered by HighWire